Q32 Bio Inc. is a clinical-stage biotechnology company developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases. Its most advanced product candidate, bempikibart (ADX-914), is a fully human anti-IL-7 receptor alpha antagonist monoclonal antibody blocking IL-7 and TSLP signaling. The company has completed Phase 2a trials in AA and atopic dermatitis and is advancing bempikibart in the ongoing SIGNAL-AA Part B trial.
expected 2026-12-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-10 | 2025-12-31 | 0001193125-26-099339 | EDGAR | 104K words |
| 2025-03-11 | 2024-12-31 | 0000950170-25-036823 | EDGAR | 108K words |
| 2024-03-13 | 2023-12-31 | 0000950170-24-030478 | EDGAR | 108K words |
| 2023-03-09 | 2022-12-31 | 0000950170-23-006995 | EDGAR | — |
| 2022-03-23 | 2021-12-31 | 0000950170-22-004401 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001564590-21-012490 | EDGAR | — |
| 2020-03-12 | 2019-12-31 | 0001564590-20-010441 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001564590-19-007250 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001193125-26-333831 | EDGAR | 69K words |
| 2025-11-13 | 2025-09-30 | 0001193125-25-278812 | EDGAR | 76K words |
| 2025-08-06 | 2025-06-30 | 0000950170-25-103530 | EDGAR | 73K words |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066371 | EDGAR | 71K words |
| 2024-11-07 | 2024-09-30 | 0000950170-24-122785 | EDGAR | 76K words |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093305 | EDGAR | 76K words |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056273 | EDGAR | 73K words |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063667 | EDGAR | 72K words |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042360 | EDGAR | 70K words |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021177 | EDGAR | 70K words |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024431 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0000950170-22-017367 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-14 | 0001193125-26-389836 | EDGAR | 2K words |
| 2026-08-05 | 0001193125-26-333813 | EDGAR | 3K words |
| 2026-07-15 | 0001193125-26-304964 | EDGAR | 22K words |
| 2026-07-13 | 0001193125-26-301520 | EDGAR | 4K words |
| 2026-07-13 | 0001193125-26-301464 | EDGAR | 2K words |
| 2026-03-27 | 0001193125-26-129431 | EDGAR | 26K words |
| 2026-03-10 | 0001193125-26-099328 | EDGAR | 3K words |
| 2026-02-17 | 0001193125-26-054711 | EDGAR | 1K words |
| 2025-12-19 | 0001193125-25-326821 | EDGAR | 1K words |
| 2025-12-01 | 0001193125-25-303115 | EDGAR | 1K words |
119 total filings indexed. 89 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001661998 |
| Ticker | QTTB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.q32bio.com |
| Listed | 2024-03-26 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/QTTB (~200 tokens, structured JSON with cryptographic provenance)